The Biological Role of Cervical Cancer Suppressor 3 (CCS-3): Literature Review
- Authors
-
-
Luigi Cristiano
R&D Division, Prestige, Loro Ciuffenna (AR), Italy
-
- Keywords:
- Cancer, EEFs, Cervical cancer suppressor 3 (CCS-3), EEF1A, Apoptosis.
- Abstract
-
CCS-3 is one of the isoforms of eEF1A1, the key protein of the translation elongation step. Discovered in 2006, it has been the subject of some studies on human cervical cancer cell lines and cervical cancer samples. These studies brought to identify its probable role as a transcriptional co-repressor but other functions are currently unknown. It has also been shown that it is able to inhibit cell growth and induce apoptosis in the tumor cells that downregulate it. Further studies could highlight its functions and its possible usefulness as a tumor marker. This review aims to brief the research about CCS-3 that has been carried out so far.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 30-12-2021
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
The Biological Role of Cervical Cancer Suppressor 3 (CCS-3): Literature Review. (2021). Journal of Cancer Research Updates, 10, 46-50. https://doi.org/10.30683/1929-2279.2021.10.06
Similar Articles
- Kevan B. Tucker, Kristina L. Makey, Edmund Chinchar, Min Huang, Natale Sheehan, Srinivasan Vijayakumar, Jian-Wei Gu, EGCG Suppresses Melanoma Tumor Angiogenesis and Growth without Affecting Angiogenesis and VEGF Expression in the Heart and Skeletal Muscles in Mice , Journal of Cancer Research Updates: Vol. 3 No. 1 (2014)
- Peng-Wei Zhang, Zhe-Sheng Chen, Zhi Shi, Targeting Snail1 by CRISPR/Cas9 System Inhibits the Proliferation and Migration of Human Gastric Cancer Cells , Journal of Cancer Research Updates: Vol. 12 (2023)
- Xingcai Zhang, Tea and Cancer Prevention , Journal of Cancer Research Updates: Vol. 4 No. 2 (2015): Special Issue - Natural Products for Cancer Prevention and Treatment
- Fatma Gharib, Rana Ali El Falah, Amr S. Ghobara, Sherehan Moeness ElShishtawy, Radwa A. Awad, Hypofractionated Versus Conventional Fractionated Radiotherapy for Patients with Triple Negative Breast Cancer: A Single Institution Randomized Trial , Journal of Cancer Research Updates: Vol. 14 (2025)
- Hirendra Banerjee, Jamel Joyner, Monet Stevenson, William Kahan, Christopher Krauss, Sasha Hodges, Eduardo Santos, Myla Worthington, Jeffferey Rousch, Gloria Payne, Vinod Manglik, Narendra Banerjee, Brianna Morris, Dayton Bell, Santosh Mandal, Short Communication: Studying the Role of Smart Flare Gold Nano Particles in Studying Micro RNA and Oncogene Differential Expression in Prostate Cancer Cell Lines , Journal of Cancer Research Updates: Vol. 6 No. 2 (2017)
- Kenichi Suda, Simon Ito, Hiroshi Mizuuchi, Yoshihiko Maehara, Yasushi Yatabe, Tetsuya Mitsudomi, EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Mian Chen, Inorganic Nanoplatforms for Simultaneous Cancer Imaging and Therapy: Status and Challenges , Journal of Cancer Research Updates: Vol. 6 No. 1 (2017)
- Atish Patel, Hui Zhang, Deshen Wang, Dong-Hua Yang, Sanjay Dholakiya, Zhe-Sheng Chen1, Pharmacotherapeutic Options for Philadelphia Chromosome-Positive CML , Journal of Cancer Research Updates: Vol. 7 No. 2 (2018)
- Raafat S. Alameddine, Nagi S. El Saghir, Elias Elias, Ahmad Saleh, Fady B. Geara, Sally Temraz, Ali Shamseddine, Effects of Nodal Status and Extent of Surgery on Survival in Triple Negative Breast Cancer , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Pankaj Deka, Amal Chandra Kataki, Debabrata Barmon, Bibhuti Bhushan Borthakur, Sushruta Shrivastava, Peritoneal Carcinomatosis with Displaced IUCD , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
You may also start an advanced similarity search for this article.